Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
Open Access
- 18 December 2008
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 6 (1), 80
- https://doi.org/10.1186/1479-5876-6-80
Abstract
Effective transvascular delivery of nanoparticle-based chemotherapeutics across the blood-brain tumor barrier of malignant gliomas remains a challenge. This is due to our limited understanding of nanoparticle properties in relation to the physiologic size of pores within the blood-brain tumor barrier. Polyamidoamine dendrimers are particularly small multigenerational nanoparticles with uniform sizes within each generation. Dendrimer sizes increase by only 1 to 2 nm with each successive generation. Using functionalized polyamidoamine dendrimer generations 1 through 8, we investigated how nanoparticle size influences particle accumulation within malignant glioma cells. Magnetic resonance and fluorescence imaging probes were conjugated to the dendrimer terminal amines. Functionalized dendrimers were administered intravenously to rodents with orthotopically grown malignant gliomas. Transvascular transport and accumulation of the nanoparticles in brain tumor tissue was measured in vivo with dynamic contrast-enhanced magnetic resonance imaging. Localization of the nanoparticles within glioma cells was confirmed ex vivo with fluorescence imaging. We found that the intravenously administered functionalized dendrimers less than approximately 11.7 to 11.9 nm in diameter were able to traverse pores of the blood-brain tumor barrier of RG-2 malignant gliomas, while larger ones could not. Of the permeable functionalized dendrimer generations, those that possessed long blood half-lives could accumulate within glioma cells. The therapeutically relevant upper limit of blood-brain tumor barrier pore size is approximately 11.7 to 11.9 nm. Therefore, effective transvascular drug delivery into malignant glioma cells can be accomplished by using nanoparticles that are smaller than 11.7 to 11.9 nm in diameter and possess long blood half-lives.Keywords
This publication has 73 references indexed in Scilit:
- Quantitative STEM and EFTEM Characterization of Dendrimer-Based Nanoparticles Used in Magnetic Resonance Imaging and Drug DeliveryMicroscopy and Microanalysis, 2008
- Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials, 2008
- Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugsNature Clinical Practice Oncology, 2008
- Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranesProceedings of the National Academy of Sciences of the United States of America, 2007
- Cell Penetrating Peptides: How Do They Do It?Journal of Biological Physics, 2007
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- AFNI: Software for Analysis and Visualization of Functional Magnetic Resonance NeuroimagesComputers and Biomedical Research, 1996
- The RG2 rat glioma modelJournal of Neuro-Oncology, 1995
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryThe New England Journal of Medicine, 1980